INTRODUCTION
Protein phosphorylation is an essential mechanism in the control of cellular signalling through various physiological pathways. Increasing attention is being paid to reversible phosphorylation events involving protein tyrosine residues, which have been implicated in such diverse aspects of cellular control as signalling by insulin and other growth factors (Ullrich and Schlessinger, 1990; Myers and White, 1993) , cell-cycle regulation (Gould et al., 1990) and the recognition of antigens by T-cells (Pingel and Thomas, 1989) . Regulation of signalling through these pathways has been shown also to involve one or more cellular protein phosphatase enzymes with a marked or absolute specificity for protein tyrosine residues (PTPases; EC 3.1.3.48) (Fischer et al., 1991; Brautigan, 1992) . In the case of the insulin holoreceptor, which retains its phosphorylation state and activation of its receptor kinase even after insulin is removed from the ligandbinding site, dephosphorylation of specific tyrosine residues is required to deactivate the intrinsic kinase activity of the receptor (Goldstein, 1993) .
A number of full-length and partial PTPase sequences have now been cloned by several laboratories (Saito and Streuli, 1991; Fischer et al., 1991; Pot and Dixon, 1992) . These enzymes comprise overlapping families of structurally related proteins with conserved cytoplasmic catalytic domains of approx. 260 amino acids that occur as single and tandemly related regions. The cloned enzymes may be divided into two broad categories: with rat LAR in the respective cytoplasmic PTPase domains, with only 57 % sequence similarity in the extracellular domain. The catalytic domains of LAR and LAR-PTP2 prepared by bacterial expression were active in dephosphorylating a variety of phosphotyrosyl substrates but did not hydrolyse phosphoserine or phosphothreonine residues of labelled casein. Both enzymes exhibited rapid turnover numbers of 4-7 s-5 for myelin basic protein and 78-150 s-5 for derivatized lysozyme. LAR and LAR-PTP2 displayed similar PTPase activity towards the simultaneous dephosphorylation of receptors of intact insulin and epidermal growth factor from liver membranes. These data indicate that there is a family of LAR-related PTPases that may regulate the phosphorylation state of receptor tyrosine kinases in liver and other tissues.
receptor-type, which have a general structure like a membrane receptor with a glycosylated extracellular domain, a single transmembrane segment and one or two conserved PTPase domains; and non-receptor-type, which lack a transmembrane segment and typically have a single PTPase domain and additional protein segments with various functional properties. Some of the non-receptor-type PTPases include PTPasel B (Guan et al., 1990; Chernoffet al., 1990; Brown-Shimer et al., 1990 ) and the T-cell PTPase (Cool et al., 1989) , which have C-terminal hydrophobic domains that confer an association with the endoplasmic reticulum, PTPH1 and MEG (Yang and Tonks, 1991; Gu et al., 1991) , which have N-terminal domains homologous to cytoskeleton-associated proteins, PTP1C (Shen et al., 1991; Plutzky et al., 1992; Yi et al., 1992) and SH-PTP2 (Freeman et al., 1992; Ahmad et al., 1993) , which have two N-terminal SH2 domains that may promote their interaction with certain phosphotyrosine-containing substrates, PEP (Matthews et al., 1992) , which has a proline-, glutamic acid-, serine-and threoninerich ('PEST') domain at the C-terminus, and HePTPase (Zanke et al., 1992) , which apparently lacks additional functional domains and appears to be a cytosolic PTPase expressed in lymphoid tissues.
The leucocyte common antigen (LCA) or CD45 (Trowbridge et al., 1991) was the first member of the family of receptor-type transmembrane PTPases to be identified. As CD45 was restricted in its expression to haematopoietic tissues, Streuli et al. (1988) used a CD45 cDNA probe to isolate a structurally related PTPase homologue from a human placental library, called the leucocyte common antigen-related phosphatase (LAR), which is expressed in liver and a variety of cell lines and tissues (Streuli et al., 1988; Goldstein et al., 1991) . Additional receptor-type PTPases have been cloned by several laboratories from mammalian tissue sources including LRP, for LCA-related phosphatase (also termed RPTP-a) (Matthews et al., 1990; Sap et al., 1990; Krueger et al., 1990) , RPTP-,/, RPTP-8, RPTP-c (Krueger et al., 1990) , RPTP-,t (Gebbink et al., 1991) and RPTP-C . Krueger et al. (1990) have also provided evidence that LAR and RPTP-8 have a close phylogenetic relationship and may comprise a subfamily of transmembrane PTPases.
Our laboratory is interested in isolating PTPases that are expressed in liver and other insulin-sensitive tissues in order to characterize their potential physiological role in the regulation of receptor tyrosine kinase activity and growth factor action. As the bulk of insulin-receptor dephosphorylating activity is localized to a particulate fraction of liver and hepatoma cells, we used a cDNA fragment from the human transmembrane PTPase, LAR, as a probe for molecular cloning ofadditional related homologues at reduced stringency in a rat liver cDNA library. A unique transmembrane PTPase homologue in the LAR family was isolated and characterized. The activity of the cytoplasmic domains of the cloned PTPases was also evaluated using a bacterial expression system and several tyrosine-phosphorylated protein substrates including intact receptors for insulin and epidermal growth factor.
EXPERIMENTAL Materials
A mixed oligo(dT) and random hexamer-primed cDNA library in AZAPII prepared from the liver of a male Sprague-Dawley rat was obtained from Stratagene (La Jolla, CA, U.S.A. (Sambrook et al., 1989) at reduced stringency in a solution containing 40 % (v/v) formamide, 0.1 % (w/v) Ficoll, 0.1 % (w/v) poly(vinylpyrrolidone), 0.1 % (w/v) BSA, 5 mM EDTA, 0.1 % (w/v) SDS, 100 ,ug/ml denatured salmon sperm DNA, 750 mM NaCl and 50 mM NaH2PO4, pH 7.4, at 35°C with a labelled cDNA (Feinberg and Vogelstein, 1983 ) encoding all but the extremes 5' end of the human LAR sequence (kindly provided by Dr. Haruo Saito, Dana Farber Cancer Institute, Boston, MA, U.S.A.). Filters were washed at 50°C in buffer containing 75 mM NaCl and 0.1 % (w/v) SDS in 7.5 mM trisodium citrate, pH 7.0. Twenty-four positive clones were obtained and plaque-purified by secondary screening with the same LAR cDNA probes. Insert-bearing pBluescript phagemids were excised from the AZAPII clones using the helper phage R408 and plasmids were prepared by infection of XL-1 Blue Escherichia coil host cells (Stratagene Cloning Systems, 1988) . In a tertiary screening involving hybridization of plasmid DNA, slot-blots were used to identify 15 clones that hybridized strongly with the LAR domain probe (HindIII/EcoRI segment). Doublestranded sequencing was then performed on both strands of the cDNA clones using the chain-termination method of Sanger et al. (1977) with T3 and T7 promoter primers, or synthetic 17-mer oligonucleotides derived from previously obtained sequences, and modified T7 DNA polymerase (U.S. Biochemical). For large (> 2 kb) inserts, nested deletions were prepared for sequencing each strand as described previously (Goldstein and Dudley, 1990) .
Additional cDNA segments were obtained by cDNA walking at high stringency in a rat brain cDNA library in AGT1O (Stratagene). The remaining segments of the PTPase cDNAs were cloned by an anchored reverse transcription PCR technique (Frohman et al., 1988) employing poly(dA) tailing with terminal transferase and amplification with Vent thermostable polymerase (New England Biolabs).
Analysis of sequence homology Sequences were tested for homology with the translated version of the GenBank database, and amino acid alignments were performed using programs in the EuGene package, both accessed through the Molecular Biology Computer Research Resource at Boston University.
Blot hybridization analyses Male Sprague-Dawley rats weighing 150-175 g were obtained from Taconic Farms (Germantown, NY, U.S.A.) and had free access to food and water before being killed. RNA was prepared from various rat tissues by the single-step method (Chomczynski and Sacchi, 1987) , and Northern-blot analysis was performed with poly(A)+ RNA as described previously (Goldstein et al., 1987) . A blot containing 2 ,ug of poly(A)+ RNA from multiple rat tissues was also hybridized according to directions supplied by the manufacturer (Clontech). Genomic DNA was isolated from rat liver (Ludwig et al., 1988) and after digestion with the indicated restriction enzyme, 5,ug was subjected to electrophoresis in a 0.8 % agarose gel in buffer consisting of 50 mM boric acid, 1 mM EDTA and 50 mM Tris/HCl, pH 7.0, denatured, and transferred to nitrocellulose. Filters were hybridized with cDNA fragments labelled by random hexamer priming (Feinberg and Vogelstein, 1983) .
Purification of bacterially expressed PTPase catalytic domains
For enzyme studies, the entire cytoplasmic domains of LAR and LAR-PTP2 were expressed as glutathione S-transferase fusion proteins in the pGEX-KG vector system using standard methods similar to those described by Hashimoto et al. (1992b) . The final subcloned products for LAR and LAR-PTP2 expression were checked by restriction mapping and sequencing of plasmid inserts.
Recombinant fusion proteins were expressed by transformation of E. coli HB1O1 with the pGEX vectors, and induction of protein synthesis and lysis of bacteria were performed as described (Hashimoto et al., 1992b) . Fusion proteins were isolated by glutathione-agarose affinity chromatography, cleaved with thrombin, and purified free of glutathione S-transferase over the glutathione-agarose column (Guan and Dixon, 1991) .
Dephosphorylation of receptors for Insulin and epidermal growth factor
Growth factor receptors were enriched from a solubilized membrane fraction of rat liver by wheat germ agglutinin-agarose chromatography (Kasuga et al., 1985) . Receptors for insulin and epidermal growth factor (4,ug of protein of the lectin column eluate) were labelled in a 0.4 ml reaction mixture containing 1 ,M insulin, 5 ,ug/ml epidermal growth factor, 5 mM MnCl2, 25 ,tM ATP, 200 1tCi of (y-32P]ATP (3000 Ci/mmol) and 0.05 % (v/v) Triton X-l00 in 50 mM Hepes, pH 7.6, at 4°C for 60 min. Unincorporated [32P]ATP was removed on a Bio-Gel P6 spin column, and 25,u portions of the labelled receptors were incubated with 1.5 ug of recombinant PTPase cytoplasmic domain protein in a 150,l reaction mixture containing 1 mM dithiothreitol (DTT) and 10 mM EDTA in 50 mM Hepes, pH 7.4, at 30 'C. After the indicated period of time, a 5 x concentrated gel sample buffer was added and 30,1 of the reaction volume was subjected to electrophoresis in gels containing SDS and 7.5% polyacrylamide (Laemmli, 1970) and analysed by autoradiography. using a cDNA segment derived from the 5' end of clone 12. Additional segments of the full-length rat LAR-PTP2 cDNA were then compiled from additional screenings of a rat brain cDNA library (clone RB22-2), and the remaining 882 bp of sequence at the 5' end was obtained by using the anchored PCR technique with rat brain mRNA (Frohman et al., 1988) . Interestingly, one cDNA clone for LAR-PTP2 from the rat brain library screening (RB22-2) had a deleted internal segment of 1086 bp that is flanked by a sequence that exactly matches regions of clone 12-1, suggesting that the LAR-PTP2 gene may generate alternatively spliced mRNA products in a tissue-specific fashion (see below).
The 6545 bp cDNA sequence of rat LAR contained a single long open reading frame of 5697 bp. The putative translational start site contains a well-conserved consensus sequence as defined by Kozak (1991) . The downstream methionine residue (Met-l 1) was postulated to be the N-terminal residue of the proprotein for human LAR (Streuli et al., 1988) , but in the rat sequence this has a less conserved consensus sequence for translation initiation. Furthermore, nine of the first ten residues of the postulated rat LAR precursor are identical with the human sequence, suggesting Dephosphorylation of additional phosphoprotein substrates MBP and RCML were phosphorylated on tyrosine residues with partially purified recombinant insulin receptors noted above and purified as described by Tonks et al. (199 la, b) . Dephosphorylated bovine casein (Sigma) was phosphorylated with the catalytic subunit of cyclic AMP-dependent protein kinase (Promega), under conditions suggested by the supplier. The 32P-labelled casein was purified by precipitation with trichloroacetic acid and dialysed into PTPase reaction buffer. After incubation at 30°C for up to 10 min, 32P released was measured by the addition of 0.90 ml of acidic charcoal mixture [0.9 M HCl, 90 mM sodium pyrophosphate, 2 mM NaH2PO4, 4% (v/v) Norit A], sedimentation of the precipitate in a Microfuge and determination of radioactivity in 0.5 ml of the supernatant (Krueger et al., 1990) . For kinetic studies using the purified recombinant PTPases, reactions were terminated at an appropriate time for the determination of initial reaction rates.
RESULTS cDNA cloning
Using the human LAR cDNA (Streuli et al., 1988) to probe a rat liver cDNA library at reduced stringency, eight clones were identified after a tertiary screening with a probe derived from a limited region of the intracellular LAR domain (HindlIl/EcoRI fragment). Among these initial cDNA clones, analysis of overlapping cDNA segments revealed that two sequences were present. One of the cDNAs was represented by seven cDNA clones. This sequence was nearly identical with the human LAR cDNA sequence and represents its rat homologue (see below).
Additional segments of the full-length rat LAR cDNA were then compiled from additional screenings of rat liver and brain cDNA libraries. The remaining 546 bp of the 5' region was obtained by an anchored PCR technique with rat liver mRNA (Frohman et al., 1988) .
One unique cDNA insert from the initial rat liver library screening (clone 12 in Figure 1 ) had high regional homology to the intracellular portion of the LAR cDNA but appeared to encode a different gene product. We have termed this cDNA LAR-PTP2. An additional segment of this relatively rare hepatic cDNA (Figure 1 , clone 9-1) was isolated by cDNA walking with an additional one million plaques of the same rat liver library (Fearon et al. 1990) Between the amino acid sequence, identical residues are indicated with a capital letter and conservative substitutions are shown by a (+). In a few cases, a single amino acid gap has been introduced for alignment (.). 
LGRQCAERNIFKDNTTLKTYFLANALEFKITELSFQLHTLTTEADPLENR Figure 3 Alignment of amino acid sequences deduced from the cDNAs for human LAR (hIAR), rat LAR (rIAR), human PTP-4 (hPTP6) and rat LAR-PTP2 (rPTP2) as determined by the algorithms In the EuGene DNA anaiysis programs
As shown, human PTP-4 contains the available partial sequence data (Krueger et al., 1990 There is a single in-frame termination codon upstream (ntl 16) of the putative translational start site (ntl85) which contains a wellconserved initiation sequence; the signal-peptide-cleavage site is predicted to occur between Gly-26 and Cys-27. Thus the mature protein contains 1837 residues, which includes an extracellular domain of 1186 residues, 25 hydrophobic residues in the single transmembrane domain (Gly-1213-Tyr-1237) and a cytoplasmic domain of 626 amino acids. The alternative sequence of the LAR-PTP2 cDNA found in clone RB22-2 from rat brain shortens the extracellular domain by 362 amino acids (Figure 1) . We have termed the protein resulting from the translation of this alternatively spliced mRNA LAR-PTP2B.
Homology comparisons with the deduced amino acid sequences of rat LAR and LAR-PTP2 were performed against the translated version of the GenBank database (Figure 2 ). Similarly to data reported for other receptor-type PTPases (Streuli et al., 1988) , the extracellular domain of both LAR and LAR-PTP2 had striking regional homologies to certain fibronectin domains (Kornblihtt et al., 1985) and portions of the neural cell adhesion molecule (N-CAM) structure (Cunningham et al., 1987) . In addition, both rat LAR and LAR-PTP2 have marked segmental homology to a putative colorectal tumour suppressor protein that has structural similarities to the N-CAM family (Fearon et al., 1990) , but whose function is unknown.
LAR and LAR-PTP2 proteins have a high degree of amino acid identity in each of the defined functional domains ( Figure   3 ). The rat LAR homologue had 95.3 % overall sequence identity to human LAR with even higher identities in the transmembrane (100 %) and cytoplasmic (98.2 %) PTPase domains. PTP-2 had an overall structural organization that was similar to that of human LAR. These features included three immunoglobulintype cysteine repeats near the N-terminus with high conservation of the consensus D-X-A(G)-X-Y-X-C sequence around the second cysteine residue of each repeat in both LAR and LAR-PTP2 (Cunningham et al., 1987) . Both proteins also exhibited eight fibronectin type-III repeats in the extracellular domain. The alternatively spliced segment of the rat brain cDNA encoding LAR-PTP2B effectively removes the fourth-sixth fibronectin type III repeats. Despite their overall conservation of sequence identity, the rat LAR and LAR-PTP2 sequences diverge significantly in many areas of the extracellular domain, especially near the transmembrane segment and in the proximal portion of the cytoplasmic domain near the membrane. Interestingly, in the internal portion, the amino acid identity between rat LAR-PTP2 and rat LAR is greater in the second PTPase region (89.6 %) than in the proximal domain (78.7 %), as has been noted for other tandem-domain PTPases (Krueger et al., 1990 The sequence origin of the cDNA probes is shown schematically in the lower panel; the hLAR probe was an EcoRl/Hindlll fragment, the rLAR probe was an EcoRl fragment of clone 18-2, and the rLAR-PTP2 probe was an Apal fragment of clone 12. Note that the EcoRl site is converted between the human and rat LAR cDNAs but is not present at that position in the rLAR-PTP2 cDNA sequence.
Blot hybridization studies Southern-blot analysis with rat genomic DNA indicated that the human LAR domain probe (HindIll/EcoRI fragment) hybridizes only with two discrete fragments of HindIII-digested rat DNA under the reduced stringency conditions used in the library screening (Figure 4) . Interestingly, the 20 kb genomic fragment hybridizes only with a cDNA segment from the PTPase domain of the rat LAR clone, whereas the 9.0 kb fragment hybridizes predominantly with the cDNA probe derived from an identical region of the conserved first PTPase domain of LAR-PTP2. These data suggest that the probe used in the initial library screening cross-reacts with genomic segments derived from the coding regions of the two closely related PTPase The expression of rat LAR and LAR-PTP2 was evaluated by Northern-blot analysis using poly(A)+ RNA from several rat tissues. In preliminary studies using the probes from the cytoplasmic domain indicated in Figure 4 seen in kidney, heart, lung, spleen, testis and skeletal muscle, with no apparent expression of the smaller mRNA species. Interestingly, brain RNA contained a transcript that co-migrated with the 4.6 kb liver mRNA for LAR and a diffuse signal suggesting additional size mRNAs. The diffuse signal might also suggest cross-reactivity with other related PTPases in brain, but this is less likely given the high stringency of the hybridization and the lack of cross-reactivity on these blots between LAR and its close homologue LAR-PTP2 (see below). The hybridization signal of the same blot with a probe for f6-actin attests to the integrity of the RNA preparation. In contrast, Northern-blot analysis of the same blot using a cDNA probe encompassing the entire cytoplasmic domain of LAR-PTP2 revealed a single mRNA transcript of 7.3 kb with predominant expression in heart, testis and liver, and lesser expression in skeletal muscle, spleen, brain and kidney ( Figure  5) . By examining the superimposed blots for LAR and LAR-PTP2, the high-molecular-size transcript for LAR is measurably larger than the LAR-PTP2 mRNA. In the blot shown in Figure  5 and in independent Northern-blot hybridizations (not shown), a major transcript for LAR-PTP2 was also observed at 6.0 kb which was expressed to a high level only in brain tissue. Additional mRNA species for LAR-PTP2 are apparent in the range of -2.6 to 4.4 kb. Reverse transcription and cDNA amplification of brain RNA with primers flanking the alternatively spliced domain of LAR-PTP2 revealed products of -1.9 kb as well as smaller products in the 200-400 bp range, providing further evidence that both forms of the LAR-PTP2 mRNA are expressed in brain tissue (results not shown). The presence of multiple splice forms of the LAR-PTP2 transcripts may also account for the broad multiple bands we and others have observed on Northern-blot analysis of PTP-2 in brain (Yan et al., 1993; Pan et al., 1993) .
(c) Figure 5 Northern-blot analysis of mRNA from several rat Ussues using rat LAR (a), LAR-PTP2 (b) and h8-actln (c) cDNAs as probes Electrophoresis in 1 % agarose gels containing 3 % (v/v) formaldehyde was performed with 2 #sg of poly(A)+ RNA from rat heart (H), brain (B), spleen (S), lung (L), liver (Li), skeletal muscle (M), kidney (K) and testis (T). The RNAs were transferred to nylon filters and hybridized at high stringency according to the manufacturer's instructions (Clontech). For these blots, the cDNA probes were the entire cytoplasmic domains of LAR and LAR-PTP2 and a 2 kb human f8-actin control probe used sequentially on the same blot. The positions of RNA size markers are also indicated.
a lesser extent in brain and spleen. These results are essentially in agreement with Northern-blot data from human cell lines (Streuli et al., 1988) . Using the entire rat LAR cytoplasmic domain as a probe, hybridization of mRNA from multiple rat tissues showed predominant expression of LAR in liver as an 8.0 kb mRNA, with two minor bands at -5.0 and -4.6 kb ( Figure 5) . In decreasing order, expression of the 8.0 kb transcript was also Catalytic activity of LAR and LAR-PTP2 cytoplasmic domains In order to examine the enzyme activity of the catalytic domains of the cloned PTPases, the entire cytoplasmic domains of LAR and LAR-PTP2 were expressed as recombinant glutathione Stransferase fusion proteins using the pGEX-KG vector. The PTPase domains were cleaved from the fusion product and purified essentially to homogeneity. Both protein domains migrated at the expected molecular size of approx. 72 kDa (results not shown).
The catalytic activity of the recombinant PTPase domains was tested in vitro towards the simultaneous dephosphorylation of intact autophosphorylated receptors for insulin and epidermal growth factor prepared from rat liver membranes (Figure 6 ). In these studies, the dephosphorylation of the 95 kDa insulin receptor f-subunit and the 170 kDa epidermal growth factor receptor protein was assessed by gel electrophoresis and autoradiography of the receptor polypeptides after incubation with the purified PTPase enzymes. In the control receptor preparation, minimal dephosphorylation of the intact receptors was observed during the incubation period. After incubation with recombinant LAR or LAR-PTP2, both autophosphorylated receptors were simultaneously dephosphorylated with no significant difference in the relative PTPase activity towards the dephosphorylation of either insulin or epidermal growth factor receptors.
The purified LAR and LAR-PTP2 cytoplasmic domains were also used to study catalytic properties of their encoded PTPases. Casein, phosphorylated with the catalytic subunit of cyclic AMPdependent protein kinase, was not dephosphorylated by either LAR or LAR-PTP2 over background (not shown). As a control, calf intestinal alkaline phosphatase (Promega) rapidly de- A series of effectors that have previously been shown to stimulate or inhibit various PTPases was tested with the LAR and LAR-PTP2 enzymes using both MBP and RCML as substrates (Table 1) . Sodium vanadate was inhibitory to both enzymes, although the Y. (IC50) was substantially higher for LAR using RCML as substrate (100 ,uM) than for MBP with either enzyme or for RCML with LAR-PTP2. Another PTPase inhibitor, ammonium molybdate, was inhibitory to both enzymes but LAR appeared less sensitive than LAR-PTP2 with both substrates. Interestingly, spermine and EDTA demonstrated similar effects on both PTPase enzymes; these compounds were moderately inhibitory to RCML dephosphorylation but stimulatory to dephosphorylation of MBP.
Kinetic parameters were also determined for LAR and LAR-PTP2 using both substrates (Table 2 ). There was a close range of Km values for these artificial substrates varying between 3 and 8 ,uM. The turnover numbers calculated for MBP were 4 and 7 s-I for LAR-PTP2 and LAR respectively assuming a single catalytic centre for each cytoplasmic domain. For RCML, these values were substantially higher (78 and 150 s-' for LAR-PTP2
and LAR respectively), indicating a marked catalytic preference of these enzymes for RCML as a substrate compared with MBP.
DISCUSSION LAR-TrP
The present study was performed initially to characterize PTPases activity (%) that occur in liver and have a potential role in the regulation of (Goldstein et al., 1991) . Other work has supported this hypothesis, including studies with permeabilized adipocytes (Mooney and Anderson, 1989 ) and insulin receptor dephosphorylation in liver endosomes (Faure et al., 1992 restricted rat genomic DNA identified only two genomic segments that appear to be derived from the genes for rat LAR and LAR-PTP2 respectively (Figure 4) . Since a third fragment corresponding to a potential rat gene for PTP-8 was not observed, these findings suggest that perhaps LAR-PTP2 and PTP-8 arose as a result of divergent molecular evolution from an ancestral LAR-related PTPase homologue that arose initially by gene duplication.
The extracellular domains of rat LAR and LAR-PTP2 share several common structural features with the human PTPases, LAR, PTP-,/ and PTP-8, and the Drosophila homologues, DPTP and DLAR (Streuli et al., 1989) . These include regional homologies to fibronectin type III domains and the related N-CAM structure (Figure 2 ). These structural determinants suggest that these transmembrane 'receptor-like' PTPases may be regulated by the homotypic interactions that are characteristic of cell adhesion molecules. Unique regions in the extracellular domains of these enzymes may interact with other cell-surface molecules or specific circulating ligands which may exert a regulatory influence on the activity of the cytoplasmic PTPase domains, as has been demonstrated in studies with recombinant epidermal growth factor receptor-CD45 chimaera (Desai et al., 1993) .
The expression of an alternatively spliced form of LAR-PTP2 (LAR-PTP2B) may also have tissue-specific functional effects, as this protein apparently lacks three of the eight fibronectin type III domains found in the extracellular domain of the full-length LAR-PTP2 expressed in liver. This sequence variation may have functional significance for the expression of LAR-PTP2 in various brain cell types or in its regional distribution. Alternative splicing of receptor-type PTPase mRNAs has been noted to affect both the extracellular and cytoplasmic domains (Streuli et al., 1987; Matthews et al., 1990; Barnea et al., 1993; Mizuno et al., 1993) . During preparation of this paper, a report appeared documenting an additional splice variant of LAR-PTP2B that differentially uses polyadenylation sites leading to a truncated cytoplasmic segment lacking the second PTPase domain (Pan et al., 1993) . Also, mapping of LAR-PTP2B in mRNA in brain by in sirn hybridization has demonstrated high levels of expression in neurons localized to the olfactory neuroepithelium (Walton et al., 1993) . Streuli et al. (1992) and Yu et al. (1992) have shown that the extracellular domain of LAR is post-translationally processed by proteolytic cleavage and is non-covalently associated with the transmembrane segment in transfected cells. Further studies by these authors also demonstrated that a conserved penta-arginine sequence at the distal end of the extracellular domain of LAR is likely to function as a proteolytic processing site. This site is fully conserved in the rat and human LAR sequences, and a similar sequence (RKRR) appears in the same region of human PTP-8. A similar polybasic motif is absent from the LAR-PTP2 protein, suggesting that LAR-PTP2 may have a different biosynthetic itinerary than LAR, and exist as an intact transmembrane PTPase with a large extracellular domain. Alternatively, LAR-PTP2 may be recognized by an enzyme with a unique specificity than can proteolytically process the extracellular domain in a fashion similar to LAR.
Expression of the recombinant cytoplasmic domains of rat LAR-PTP2 and LAR in a bacterial system revealed that they encode active PTPase enzymes. In in vitro studies, the catalytic domains of rat LAR and LAR-PTP2 demonstrated a lack of specificity for the two holoreceptor substrates, whose autophosphorylated tyrosine residues occur in completely different sequence contexts. These results are similar to the dephosphorylseries of transmembrane PTPases including LAR, PTP-a, PTP-,B and PTP-6 as reported by Krueger et al. (1990) , where the ratio of activity between the peptide and protein substrates among these PTPases varied only between 0.28 and 0.33. However, there may be site-specific differences in the dephosphorylation of individual sites by LAR and LAR-PTP2 in the multiply phosphorylated protein substrates, as we have also demonstrated in vitro for the cytoplasmic domain of rat LAR compared with rat LRP (PTP-a) and PTPaselB (Hashimoto et al., 1992a) .
Kinetic parameters calculated for homogeneously purified LAR and LAR-PTP2 showed they have high turnover numbers for both MBP and RCML (Table 2) . LAR had a higher specific activity with linear reaction rates than LAR-PTP2, although the Km values were also slightly higher for LAR. The calculated turnover numbers for LAR of 7 s-' for MBP and 150 s-I for RCML are similar to those reported for the rat LAR cytoplasmic domain of 3-6 s-' using p-nitrophenyl phosphate or phosphorylated angiotensin I respectively (Pot et al., 1991) and 20-70 s-5 in experiments using a variety of non-radioactive phosphotyrosyl peptides (Cho et al., 1991 (Cho et al., , 1992 .
As the intracellular domains of several of the transmembrane PTPases appear to have functional similarities, it is likely that their potential in vivo substrate specificity and their physiological roles are determined by the specificity of their tissue expression, as well as the structure of the extracellular domains in the intact proteins which may affect their interaction with cell surface proteins or regulatory ligands. Rat LAR and PTP-2 have strikingly divergent sequences in the region immediately surrounding the transmembrane domain and in the extracellular domain which may influence the function of these proteins in intact cells. Furthermore, subtle variations in the catalytic sequence of these PTPases, or the possible influence of specific cellular protein PTPase inhibitors (Ingrebritsen, 1989) , may also direct their specificity or activity towards their actual physiological substrates in vivo. Further studies involving eukaryotic expression of various membrane-linked and soluble forms of the cloned PTPases in appropriate host cells will allow these hypotheses to be tested more directly.
